Table II.
Background MN frequency and risk of PC
| MN | Patient |
Control |
OR (95% CI)a | OR (95% CI)b | ||
| N | % | N | % | |||
| Overallc | ||||||
| Low | 73 | 21.1 | 253 | 56.3 | 1.0 | 1.0 |
| High | 273 | 78.9 | 196 | 45.7 | 4.75 (3.40–6.63) | 8.32 (5.06–13.67) |
| ≤10 | 74 | 21.4 | 247 | 55.0 | 1.0 | 1.0 |
| >10 | 272 | 78.6 | 202 | 45.0 | 5.96 (4.14–8.57) | 9.0 (5.16–15.68) |
| Women | ||||||
| ≤12 | 42 | 28.2 | 113 | 53.3 | 1.0 | 1.0 |
| >12 | 107 | 71.8 | 99 | 46.7 | 2.92 (1.80–4.74) | 4.19 (1.90–9.27) |
| Men | ||||||
| ≤9 | 31 | 15.7 | 140 | 59.1 | 1.0 | 1.0 |
| >9 | 166 | 84.3 | 97 | 40.9 | 7.25 (4.50–11.69) | 14.19 (7.09–28.40) |
a
OR was adjusted for age, sex, race, smoking, alcohol consumption, history of diabetes and family history of cancer.
b
OR was adjusted for age, sex, race, smoking, alcohol consumption, history of diabetes, family history of cancer and BMI.
c
Overall: low and high used the median control value in women (≤12 or >12) and men (≤9 or >9) separately. The median control value of the control group including both women and men was 10.